Insulin Resistance in Pulmonary Arterial Hypertension

NCT00825266 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped difficulty in finding eligible subjects

Conditions

Hypertension, Pulmonary

Interventions

DRUG: bosentan
DRUG: Pioglitazone

Sponsor

Stanford University